Detalhe da pesquisa
1.
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function.
Immunity
; 51(6): 1074-1087.e9, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784108
2.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
3.
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Blood
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557775
4.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
5.
Discovery of Transacting Long Noncoding RNAs That Regulate Smooth Muscle Cell Phenotype.
Circ Res
; 132(7): 795-811, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852690
6.
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.
EMBO Rep
; 24(10): e56279, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489735
7.
Comprehensive Integration of Multiple Single-Cell Transcriptomic Data Sets Defines Distinct Cell Populations and Their Phenotypic Changes in Murine Atherosclerosis.
Arterioscler Thromb Vasc Biol
; 44(2): 391-408, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152886
8.
Genome-Wide Genetic Associations Prioritize Evaluation of Causal Mechanisms of Atherosclerotic Disease Risk.
Arterioscler Thromb Vasc Biol
; 44(2): 323-327, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266112
9.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839452
10.
Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
Circ Res
; 130(10): 1510-1530, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430876
11.
ZEB2 Shapes the Epigenetic Landscape of Atherosclerosis.
Circulation
; 145(6): 469-485, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990206
12.
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial.
Br J Haematol
; 200(5): 573-578, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413792
13.
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Cancer Immunol Immunother
; 72(3): 543-560, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962843
14.
Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm.
Arterioscler Thromb Vasc Biol
; 42(9): 1154-1168, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861960
15.
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients.
Invest New Drugs
; 40(2): 314-321, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735674
16.
Coronary Disease-Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway.
Circ Res
; 126(4): 517-529, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815603
17.
Varying Dosages of Subcutaneous Unfractionated Heparin and Activated Partial Thromboplastin Time in Hospitalized Antepartum Patients: A Retrospective Cohort Analysis.
Anesth Analg
; 134(5): 1028-1034, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020621
18.
Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions.
Circulation
; 142(6): 575-590, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441123
19.
Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors.
Invest New Drugs
; 39(6): 1633-1640, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287772
20.
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Invest New Drugs
; 39(5): 1375-1382, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856599